Guang-Sheng Ling

9PUBLICATIONS
68CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursInnate immunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 20, 2026
Targeting immunometabolism in cancer through pharmacological and lifestyle interventions.

Rachael Julia Yuenyinn Tan, Yalei Liu, Weixin Chen

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|May 21, 2025
Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.

Nelson K L Ng, Stephen S Y Lam, Lichuan Zheng

|Dec 05, 2024
Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma.

Jia Ming Nickolas Teo, Zhulin Chen, Weixin Chen

|Oct 09, 2024
Neutrophil plasticity in liver diseases.

Jia Ming Nickolas Teo, Weixin Chen, Guang Sheng Ling

|Mar 08, 2024
PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness.

Ronghui Liang, Zi-Wei Ye, Zhenzhi Qin

Pageof 2